A doctor who was at the forefront of providing gender affirming hormone therapy to transgender youth in Canada has publicly stated her current belief that most children should not be medicalized. Dr. Susan Vaughan, one of the earliest physicians to offer such treatments in the country, has experienced a significant evolution in her professional perspective. Her change of heart stems from observing the long-term outcomes for many of the young people she treated in the past.
A Shifting Perspective on Early Intervention
Dr. Vaughan’s initial work involved pioneering pathways for trans youth to access medical care, including puberty blockers and cross-sex hormones. She recalls a time when the understanding and protocols surrounding gender dysphoria in minors were less developed. Her commitment was to offer what was then considered best practice to alleviate distress for young people experiencing gender incongruence. However, after many years, she has come to a different conclusion about the most appropriate course of action for many of these young individuals.
Her current stance is that a more comprehensive and cautious approach is warranted. Dr. Vaughan suggests that for a significant number of young patients presenting with gender dysphoria, medical intervention might not be the optimal or necessary solution. This does not diminish the validity of gender diversity or the need for care, but rather calls for a re-evaluation of when and how medical treatments are employed.
Prioritizing Psychological Exploration
The doctor now emphasizes the importance of extensive psychological assessment and exploration for youth questioning their gender identity. She believes that a period of non-medicalized support, focusing on understanding the underlying issues and providing mental health support, should often precede any consideration of medical interventions like hormone therapy. This approach aims to ensure that young people are making fully informed decisions, with a deep understanding of themselves and the potential implications of medical transition.
Dr. Vaughan’s evolving viewpoint is a testament to the dynamic nature of medical understanding and practice, particularly in a relatively new and complex field like transgender healthcare for minors. Her willingness to publicly share her re assessment, after being an early adopter of specific treatments, is likely to spark further dialogue and scrutiny within the medical community and among parents. It signals a growing conversation about the balance between providing accessible care and ensuring the most beneficial and least harmful long-term outcomes for vulnerable young patients. Her journey underscores the need for ongoing critical analysis and adaptation in medical guidelines as more data and real-world experience become available.
